| Authors: |
Jackson ML; Department of Ophthalmology, University of British Columbia, Vancouver, Canada., Virgili G; Department of NEUROFARBA, Eye Clinic, Careggi University Hospital, University of Florence, Florence, Italy; and Centre for Public Health, Queen's University Belfast, Belfast, United Kingdom., Shepherd JD; Weigel Williamson Center for Visual Rehabilitation, Department of Ophthalmology & Visual Sciences, University of Nebraska Medical Center, Omaha, Nebraska., Di Nome MA; Departments of Ophthalmology, Neurosurgery, Mayo Clinic, Phoenix, Arizona., Fletcher DC; University of Kansas Medical Center, Department of Ophthalmology and KU Eye Center, Kansas City, Kansas and Retina Consultants of Southwest Florida, Ft. Myers, Florida, Envision, Wichita, Kansas., Kaleem MA; Wilmer Eye Institute, Johns Hopkins School of Medicine, Baltimore, Maryland., Lam LA; USC Roski Eye Institute, University of Southern California (USC) Keck School of Medicine, Los Angeles, California., Lawrence LM; Private Practice, Salina, Kansas., Sunness JS; Hoover Low Vision Rehabilitation Services and Department of Ophthalmology, Greater Baltimore Medical Center, Towson, Maryland; and Ophthalmology, University of Maryland School of Medicine, Baltimore, Maryland., Riddering AT; Henry Ford Health, Department of Ophthalmology, Detroit, Michigan. |